Yanez Michelle
SEC insider (Form 3/4/5 filer). CIK 0001958023. Director at Inhibitor Therapeutics, Inc. (INTI) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in TAMPA, FL.
Companies Yanez Michelle has filed insider reports for
- Inhibitor Therapeutics, Inc. (INTI): Director
- MIRA PHARMACEUTICALS, INC. (MIRA): Officer, Chief Financial Officer
- Telomir Pharmaceuticals, Inc. (TELO): Officer, Chief Financial Officer
Yanez Michelle
CIK: 0001958023
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 4, 2026INTI
Inhibitor Therapeutics, Inc.
AwardDirect50K shares- - Apr 1, 2025INTI
Inhibitor Therapeutics, Inc.
AwardDirect50K shares- - Dec 9, 2024MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirectStock Options (right to buy)
150K shares- - Dec 2, 2024INTI
Inhibitor Therapeutics, Inc.
GiftDirect250K shares- - Aug 27, 2024TELO
Telomir Pharmaceuticals, Inc.
AwardDirectIncentive Stock Options (right to buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 |  INTI Inhibitor Therapeutics, Inc. | Award | 50,000 | - | $0 | Direct |
| Apr 1, 2025 | INTI Inhibitor Therapeutics, Inc. | Award | 50,000 | - | - | Direct |
| Dec 9, 2024 |  MIRA MIRA PHARMACEUTICALS, INC. | Award Stock Options (right to buy) | 150,000 | - | - | Direct |
| Dec 2, 2024 | INTI Inhibitor Therapeutics, Inc. | Gift | 250,000 | - | - | Direct |
| Aug 27, 2024 |  TELO Telomir Pharmaceuticals, Inc. | Award Incentive Stock Options (right to buy) | 200,000 | - | - | Direct |
1-5 of 5 transactions